Brandon Capital

Brandon Capital Partners is a funds management business aiming to generate quality returns for Australia’s leading superannuation funds by investing in innovative life science ventures. Our team works with entrepreneurs to build businesses, creating value for the entrepreneurs, their teams and our investors.

GBS Venture Partners Limited

GBS Venture Partners (GBS) is a leading life science venture capital group resulting from a November 2002 management buyout of Rothschild Bioscience Managers Limited from NM Rothschild & Sons (Aust) Ltd. GBS invests in and adds value to high growth companies involved in innovative technologies such as:

• human therapeutics and diagnostics
• animal therapeutics and diagnostics
• medical devices
• health information technology
• agribusiness, food and environmental technology

GBS invests at the seed, start-up or early expansion stage of company development.

Intersuisse Bioscience Managers Pty Ltd

Intersuisse Bioscience Managers (IB managers) specialise in funds management and corporate advisory expertise.

Trans Tasman Commercialisation Fund (TTCF)

The Trans Tasman Commercialisation Fund (TTCF) is a collaboration between leading universities across South Eastern Australia and New Zealand, and a capital provider – Westscheme, Western Australia’s largest non-government Superannuation Fund.